Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

05.4

73.3

44%License revenue

--

2.9

--

--

3.1

--Total revenues

$42.0

$32.0

31%

$105.4

$76.4

38%Net revenues for the third quarter ended September 30, 2010, were $42.0 million, an increase of 31% over the third quarter of 2009.  Net revenue growth was driven primarily by strong demand for XIBROM™ and BEPREVE, supported by revenue increases in VITRASE®.  In the third quarter of 2009, ISTA recognized $2.9 million of previously deferred license revenue associated with the termination of a supply agreement.  Excluding the recognition of deferred license revenue in 2009, net product revenues increased 44% in third quarter 2010 over third quarter 2009.

Gross margin for the third quarter ended September 30, 2010, was 77%, or $32.3 million, as compared to 77%, or $24.7 million, for the same period in 2009.  Product gross margin was 77% for the third quarter 2010 and was 75% for the third quarter ended September 30, 2009.  Product gross margin improved due to increased sales of our higher gross margin products, XIBROM and BEPREVE.

Research and development (R&D) expenses for the quarter ended September 30, 2010, were $7.9 million, as compared to $6.3 million during the corresponding period of 2009.  The increase over the prior-year period was due primarily to the timing, initiation and completion of clinical trials.  ISTA initiated its Phase 1/2 clinical program for bepotastine nasal spray in July and its REMURA Phase 3 clinical program for dry eye disease in September.

Selling, general, and administrative, or SG&A, expenses for the quarter ended September 30, 2010, increased to $19.6 million from $13.2 million for the corresponding period in 2009.  The increase over the prior-year period reflects the addition of approximately 65 new sales representatives and related corporate new hires earlier in the
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WOODLANDS, Texas , April 27, 2015   ... biopharmaceutical company focused on developing breakthrough treatments for human ... on Wednesday, April 29, 2015 after the financial markets ... webcast to discuss clinical development progress and financial results ... Time on April 29, 2015. The dial-in ...
(Date:4/27/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that it has received ... Drug Administration ("FDA") verifying that the Company has successfully ... letter it received from the FDA in January 2013. ... March 2015 by the FDA at CryoLife,s manufacturing facility ...
(Date:4/27/2015)... 2015 Numerous Zofran birth defects lawsuits ( ... have highlighted serious concerns surrounding the use of prescription ... the U.S. Centers for Disease Control (CDC), ... have enough information to determine their safety for use ... in the U.S. take at least one medication during ...
Breaking Medicine Technology:Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3
(Date:4/27/2015)... MD (PRWEB) April 27, 2015 Jesse ... the 2015–2020 United States Pharmacopeial Convention (USP) at the ... is Professor of Medicine at Georgetown University and the ... and Stewardship (COMPASS). , As USP President, a volunteer ... Convention Meeting. He will be a voting member, ex ...
(Date:4/27/2015)... MN (PRWEB) April 27, 2015 Based ... Secura Consultants is one of the few insurance marketing ... in the income and asset protection markets as well ... the industry has afforded Secura Consultants the opportunity to ... to make doing business easier and quicker. , An ...
(Date:4/27/2015)... 27, 2015 Array Health , ... has announced that Lance Hood, senior director of marketing, ... annual Direct-to-Consumer Health Care Marketing Summit on ... Smith, Partner and Director of Payer Services, Leavitt Partners, ... consumerism – through a retail/e-commerce perspective – and equip ...
(Date:4/27/2015)... Thanks to a $7.5 million grant from the ... including American University, will operate in a new center ... research aimed at ending the AIDS epidemic. , Nearly ... or AIDS, according to the latest statistics. At the ... the age of 13 was living with HIV, well ...
(Date:4/27/2015)... Sitting or standing for long periods of time ... for those whose occupation requires them to be sitting while ... or to be on their feet for most of the ... more severe and longer lasting. These people suffer from a ... of Northeast Houston Vein Center is offering tips on how ...
Breaking Medicine News(10 mins):Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3
... the latest medicine kings in the treatment of many complex ... in the June issue of Angiology if pine bark extract ... of muscles. ,The reason and scientific basis behind ... to the muscles which speeds recovery after physical exercise. ...
... the chikungunya disease all over the country and in Tamil ... Director, Vector borne Diseases, Tamil Nadu, said today. ... ,Preventive measures are on to restrict the ... a seminar on sensitization programme for medical staff and students ...
... red wines have a sleep inducing ingredient, melatonin. That’s probably the ... hormone is produced by the pineal gland in the brain, which ... hit the sack! , ,The discovery of melatonin in ... bottle in the evening to wind down after a day's hard ...
... receptor activity in the postmortem brain tissue from patients ... of Medicine, in collaboration with scientists at the City ... in its function. A high level of erbB4 receptor ... the receptors in the prefrontal cortex of schizophrenic patient ...
... of subjecting drug addicts to shock therapy as a means ... controversies. Now, the Scottish Executive is doing more research into ... labeled as Neuro-Electric Therapy (NET) is executed with the use ... pulses are sent into the brain. This is known to ...
... center, a tuberculosis case alerts the health authorities //. ... worker, who works at the Centenary Childcare and Early ... ,Dr Michael Whitby, a spokesman of Australian Medical ... the center are at risk of getting infected. ...
Cached Medicine News:Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
... RSV Test utilizes a new, improved format that ... rapid RSV detection. The testing device employs innovative ... reagents have already been applied to the testing ... with clear-cut results shown by the appearance of ...
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: